Cargando…
Clinical validation of an autoantibody test for lung cancer
Background: Autoantibodies may be present in a variety of underlying cancers several years before tumours can be detected and testing for their presence may allow earlier diagnosis. We report the clinical validation of an autoantibody panel in newly diagnosed patients with lung cancer (LC). Patients...
Autores principales: | Boyle, P., Chapman, C. J., Holdenrieder, S., Murray, A., Robertson, C., Wood, W. C., Maddison, P., Healey, G., Fairley, G. H., Barnes, A. C., Robertson, J. F. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3030465/ https://www.ncbi.nlm.nih.gov/pubmed/20675559 http://dx.doi.org/10.1093/annonc/mdq361 |
Ejemplares similares
-
Technical validation of an autoantibody test for lung cancer
por: Murray, A., et al.
Publicado: (2010) -
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
por: Chapman, Caroline J., et al.
Publicado: (2012) -
Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma
por: Middleton, Catrin H., et al.
Publicado: (2014) -
Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection
por: Macdonald, Isabel K., et al.
Publicado: (2012) -
Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT(®)-Lung Test
por: Macdonald, Isabel K., et al.
Publicado: (2012)